Exact Mass: 362.0782

Exact Mass Matches: 362.0782

Found 49 metabolites which its exact mass value is equals to given mass value 362.0782, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

7-O-Galloyl-sedoheptulose

(2,3,4,5,7-Pentahydroxy-6-oxoheptyl) 3,4,5-trihydroxybenzoate

C14H18O11 (362.0849)


   

Resomycin C

Resomycin C

C21H14O6 (362.079)


   

Tephcalostan

8,9-Methylenedioxy-5-(1-methylethenyl)-4,5-dihydrofurano[2,3:3,2]-coumestan

C21H14O6 (362.079)


   
   
   

14-Methoxyhalenaquinone

14-Methoxyhalenaquinone

C21H14O6 (362.079)


   

Methyl 18-Bromo-(17Z)-octadeca-17-ene-5,7,15-triynoate

Methyl 18-Bromo-(17Z)-octadeca-17-ene-5,7,15-triynoate

C19H23BrO2 (362.0881)


   

Neopusticin ?

Neopusticin ?

C21H14O6 (362.079)


   

podocarflavone A

podocarflavone A

C21H14O6 (362.079)


   

canaliculatin

canaliculatin

C21H14O6 (362.079)


   

15-methoxyhalenaquinone

15-methoxyhalenaquinone

C21H14O6 (362.079)


   

Methyl 18-Bromo-(9Z,15Z,17E)-octadeca-9,15,17-triene-5,7-diynoate

Methyl 18-Bromo-(9Z,15Z,17E)-octadeca-9,15,17-triene-5,7-diynoate

C19H23BrO2 (362.0881)


   

5-(4,4,6-trimethyl-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)naphthalene-2-sulfonic acid

5-(4,4,6-trimethyl-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)naphthalene-2-sulfonic acid

C17H18N2O3S2 (362.0759)


   

Methyl 18-bromooctadec-17-en-5,7,15-triynoate

Methyl 18-bromo-17E-octadecen-5,7,15-triynoate

C19H23BrO2 (362.0881)


   

Methyl 18-bromo-17Z-octadecen-5,7,15-triynoate

Methyl 18-bromo-17Z-octadecen-5,7,15-triynoate

C19H23BrO2 (362.0881)


   

Methyl 18-bromo-9E,15E,17E-octadecatrien-5,7-diynoate

Methyl 18-bromo-9E,15E,17E-octadecatrien-5,7-diynoate

C19H23BrO2 (362.0881)


   

Methyl 18-bromooctadec-17-en-5,7,15-triynoate

Methyl 18-bromo-17E-octadecen-5,7,15-triynoate

C19H23O2Br (362.0881)


   

Methyl 18-bromo-17Z-octadecen-5,7,15-triynoate

Methyl 18-bromo-17Z-octadecen-5,7,15-triynoate

C19H23O2Br (362.0881)


   

Methyl 18-bromo-9E,15E,17E-octadecatrien-5,7-diynoate

Methyl 18-bromo-9E,15E,17E-octadecatrien-5,7-diynoate

C19H23O2Br (362.0881)


   

7-chloro-1-(2,3-dihydroxypropyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one

7-chloro-1-(2,3-dihydroxypropyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one

C18H16ClFN2O3 (362.0833)


   

4-[3-(3,4-dicyanophenoxy)phenoxy]benzene-1,2-dicarbonitrile

4-[3-(3,4-dicyanophenoxy)phenoxy]benzene-1,2-dicarbonitrile

C22H10N4O2 (362.0804)


   

4-BENZYLOXY-5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)-PYRIMIDINE

4-BENZYLOXY-5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)-PYRIMIDINE

C16H19BrN4O (362.0742)


   

Piperazine-1,4-bis(2-hydroxypropanesulfonic acid) dihydrate

Piperazine-1,4-bis(2-hydroxypropanesulfonic acid) dihydrate

C10H22N2O8S2 (362.0818)


   

(R)-3-((6,7,8,9-TETRAHYDRO-5H-BENZO[7]ANNULEN-5-YL)THIO)-5-UREIDOISOTHIAZOLE-4-CARBOXAMIDE

(R)-3-((6,7,8,9-TETRAHYDRO-5H-BENZO[7]ANNULEN-5-YL)THIO)-5-UREIDOISOTHIAZOLE-4-CARBOXAMIDE

C16H18N4O2S2 (362.0871)


   
   

Trimethyl[1-(2,6-xylylcarbamoyl)ethyl]ammonium iodide

Trimethyl[1-(2,6-xylylcarbamoyl)ethyl]ammonium iodide

C14H23IN2O (362.0855)


   

4-(dimethylsulfamoyl)-N-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

4-(dimethylsulfamoyl)-N-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

C15H14N4O5S (362.0685)


   

1,5-Dihydroxy-4,8-bis(hydroxy(hydroxymethyl)amino)anthraquinone

1,5-Dihydroxy-4,8-bis(hydroxy(hydroxymethyl)amino)anthraquinone

C16H14N2O8 (362.075)


   

6-(1,3-benzodioxol-5-yl)-N-(2-thiazolylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(2-thiazolylmethyl)-4-quinazolinamine

C19H14N4O2S (362.0837)


   

4-chloro-N-[4-[3-(methylthio)anilino]-4-oxobutyl]benzamide

4-chloro-N-[4-[3-(methylthio)anilino]-4-oxobutyl]benzamide

C18H19ClN2O2S (362.0856)


   

2-[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]-N-phenylacetamide

2-[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]-N-phenylacetamide

C19H14N4O2S (362.0837)


   

3-[(1,3-benzothiazol-2-ylthio)methyl]-4-cyclohexyl-1H-1,2,4-triazole-5-thione

3-[(1,3-benzothiazol-2-ylthio)methyl]-4-cyclohexyl-1H-1,2,4-triazole-5-thione

C16H18N4S3 (362.0694)


   

8-Chloro-7-[2-(4-methoxyphenyl)-2-oxoethyl]-1,3-dimethylpurine-2,6-dione

8-Chloro-7-[2-(4-methoxyphenyl)-2-oxoethyl]-1,3-dimethylpurine-2,6-dione

C16H15ClN4O4 (362.0782)


   

Cefadroxil(1-)

Cefadroxil(1-)

C16H16N3O5S- (362.0811)


A cephalosporin carboxylic acid anion having a 7beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino side-chain, formed by proton loss from the carboxy group of the cephalosporin cefadroxil.

   

BZAD-01

BZAD-01

C16H12F6N2O (362.0854)


BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit, with a Ki of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation[1].

   

ZINC00784494

ZINC00784494

C20H14N2O3S (362.0725)


ZINC00784494 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00784494 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00784494 has good potential for research in inflammatory breast cancer (IBC)[1].

   

methyl (9z,15z,17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate

methyl (9z,15z,17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate

C19H23BrO2 (362.0881)


   

methyl (17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate

methyl (17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate

C19H23BrO2 (362.0881)


   

methyl (17e)-18-bromooctadec-17-en-5,7,15-triynoate

methyl (17e)-18-bromooctadec-17-en-5,7,15-triynoate

C19H23BrO2 (362.0881)


   

methyl 2-(4-hydroxy-3-{[2-hydroxy-5-(2-methoxy-2-oxoethyl)phenyl]sulfanyl}phenyl)acetate

methyl 2-(4-hydroxy-3-{[2-hydroxy-5-(2-methoxy-2-oxoethyl)phenyl]sulfanyl}phenyl)acetate

C18H18O6S (362.0824)


   

6,6-dimethyl-5,12,18,20,24-pentaoxahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²¹]tetracosa-1(14),2(11),3,7,9,15(23),16,21-octaen-13-one

6,6-dimethyl-5,12,18,20,24-pentaoxahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²¹]tetracosa-1(14),2(11),3,7,9,15(23),16,21-octaen-13-one

C21H14O6 (362.079)


   

5-hydroxy-3-(4-hydroxy-5-methyl-2-oxochromen-3-yl)-2-methylnaphthalene-1,4-dione

5-hydroxy-3-(4-hydroxy-5-methyl-2-oxochromen-3-yl)-2-methylnaphthalene-1,4-dione

C21H14O6 (362.079)


   

(1r,1'r,10'r,12'r)-7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

(1r,1'r,10'r,12'r)-7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

C21H14O6 (362.079)


   

methyl (17z)-18-bromooctadec-17-en-5,7,15-triynoate

methyl (17z)-18-bromooctadec-17-en-5,7,15-triynoate

C19H23BrO2 (362.0881)


   

7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

C21H14O6 (362.079)


   

(1s)-7-methoxy-1-methyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2(11),3,6,9,13(20),15-hexaene-5,8,12,17-tetrone

(1s)-7-methoxy-1-methyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2(11),3,6,9,13(20),15-hexaene-5,8,12,17-tetrone

C21H14O6 (362.079)


   

(6s)-6-(prop-1-en-2-yl)-7,11,17,19,23-pentaoxahexacyclo[11.10.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tricosa-1(13),2(10),3,8,14(22),15,20-heptaen-12-one

(6s)-6-(prop-1-en-2-yl)-7,11,17,19,23-pentaoxahexacyclo[11.10.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tricosa-1(13),2(10),3,8,14(22),15,20-heptaen-12-one

C21H14O6 (362.079)


   

methyl (9e,15z,17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate

methyl (9e,15z,17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate

C19H23BrO2 (362.0881)


   

methyl 5,7-dihydroxy-2-methyl-6,11-dioxotetracene-1-carboxylate

methyl 5,7-dihydroxy-2-methyl-6,11-dioxotetracene-1-carboxylate

C21H14O6 (362.079)